Celcuity Director Buys Shares on Vesting Schedule, Signaling Growing Insider Confidence
Celcuity insider buying signals confidence: Charles Romp’s 215‑share stake on vesting shows long‑term commitment, hinting at upside as clinical milestones loom.
2 minutes to read


